Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/14/2023 | 212.5% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
07/18/2023 | 212.5% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
06/23/2023 | 212.5% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
05/15/2023 | 212.5% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
05/01/2023 | 212.5% | HC Wainwright & Co. | → $5 | Initiates Coverage On | → Buy |
03/27/2023 | -37.5% | Morgan Stanley | $2 → $1 | Maintains | Underweight |
01/24/2023 | 25% | Morgan Stanley | $3 → $2 | Maintains | Underweight |
09/14/2022 | 87.5% | Morgan Stanley | → $3 | Maintains | Underweight |
What is the target price for Invivyd (IVVD)?
The latest price target for Invivyd (NASDAQ: IVVD) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $5.00 expecting IVVD to rise to within 12 months (a possible 212.50% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Invivyd (IVVD)?
The latest analyst rating for Invivyd (NASDAQ: IVVD) was provided by HC Wainwright & Co., and Invivyd reiterated their buy rating.
When is the next analyst rating going to be posted or updated for Invivyd (IVVD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Invivyd, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Invivyd was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
Is the Analyst Rating Invivyd (IVVD) correct?
While ratings are subjective and will change, the latest Invivyd (IVVD) rating was a reiterated with a price target of $0.00 to $5.00. The current price Invivyd (IVVD) is trading at is $1.60, which is within the analyst's predicted range.